Raj Mehra - 31 Mar 2022 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role: President, Chief Executive Officer and Chairman of the Board of Directors, Director
Signature: /s/ Raj Mehra
Issuer symbol: SEEL
Transactions as of: 31 Mar 2022
Transactions value $: $56,840
Form type: 4
Filing time: 31 Mar 2022, 16:34:22 UTC
Previous filing: 11 Jan 2022
Next filing: 31 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SEEL	Common Stock	Purchase	$56.8K	+66.7K	+2.07%	$0.85	3.28M	31 Mar 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Content

The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Remarks:

President, Chief Executive Officer and Chairman of the Board of Directors